Status:
COMPLETED
The Prognostic Impact of Extracapsular Lymph Node Involvement in Ductal Pancreatic Adenocarcinoma
Lead Sponsor:
KU Leuven
Collaborating Sponsors:
Agentschap voor Innovatie door Wetenschap en Technologie
Conditions:
Pancreatic Neoplasms
Pancreatic Adenocarcinoma
Eligibility:
All Genders
Brief Summary
Extracapsular lymph node involvement (ECLNI) has been identified as a pathological variable associated with worse outcome in esophageal, gastric and colorectal cancer. No studies so far have studied i...
Detailed Description
Presence and extent of extracapsular lymph node involvement (ECLNI) will be scored by reviewing all original pathological slides. ECLNI is defined as metastatic adenocarcinoma extending through the n...
Eligibility Criteria
Inclusion
- DPAC
- Primary resection
Exclusion
- Positive section margins
- non DPAC, other tumor
- Postoperative mortality
- Neoadjuvant chemo/radiotherapy
Key Trial Info
Start Date :
October 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2008
Estimated Enrollment :
145 Patients enrolled
Trial Details
Trial ID
NCT00644254
Start Date
October 1 2007
End Date
March 1 2008
Last Update
July 7 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Abdominal Surgery
Leuven, Vlaams-Brabant, Belgium, 3000